Champions Oncology (CSBR) Cash from Operations (2010 - 2026)

Champions Oncology (CSBR) has 17 years of Cash from Operations data on file, last reported at -$492000.0 in Q3 2026.

• On a quarterly basis, Cash from Operations fell 182.0% year-over-year to -$492000.0 in Q3 2026; TTM through Jul 2026 was -$5.6 million, a 172.5% decrease from a year earlier, with the FY2026 full-year figure at -$4.5 million, down 160.55% from the prior year.
• Cash from Operations for Q3 2026 stood at -$492000.0, up from -$2.0 million in the prior quarter.
• Across five years, Cash from Operations topped out at $6.9 million in Q2 2025 and bottomed at -$4.0 million in Q3 2023.
• Historically, Cash from Operations has averaged $279473.7 across 5 years, with a median of -$195000.0 in 2022.
• The widest annual swing landed in 2022, when Cash from Operations jumped 3053.33%; it then sank 1946.67% in 2023.
• Year by year, Cash from Operations stood at $3.3 million in 2022, then tumbled by 82.08% to $589000.0 in 2023, then slumped by 148.05% to -$283000.0 in 2024, then plunged by 513.07% to -$1.7 million in 2025, then surged by 71.64% to -$492000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were -$492000.0 in Q3 2026, -$2.0 million in Q2 2026, and -$1.3 million in Q1 2026.